SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-010057
Filing Date
2020-08-10
Accepted
2020-08-10 08:23:58
Documents
5
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20200810x8k.htm 8-K 36911
2 EX-99.1 axsm-20200810xex99d1.htm EX-99.1 86930
3 EX-99.2 axsm-20200810xex99d2.htm EX-99.2 37466
4 GRAPHIC axsm-20200810xex99d1001.jpg GRAPHIC 4928
5 GRAPHIC axsm-20200810xex99d2001.jpg GRAPHIC 4446
  Complete submission text file 0001558370-20-010057.txt   175698
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 201087227
SIC: 2834 Pharmaceutical Preparations